About Event
Welcome to the IMPACCT Real World Evidence Europe's content hub where all speaker interviews will be posted available for download. This is your go-to space for hearing from the speakers directly: their backgrounds, thoughts and more dynamic conversations about their talks coming to Amsterdam this June.
Our Speaker Interviews
Speaker Interview: Lill-Brith Wium Von Arx for Eli Lilly & Company
To celebrate International Women's Day, we sat Lill-Brith down for an interview about her experience, journey and life lessons across the RWE space. Take a look into her early career, her inspirational female leaders and her advice for navigating a leadership position as a woman.
In Amsterdam this June, Lill-Brith Wium Von Arx will join 19 other expert speakers to share their insights on the RWE world, the challenges the lay ahead and potential solutions. Unite to network with peers, learn practical tups and get inspired by what the future looks like.
"With great complexity in data structures and diagnostic/treatment coding, more than ever, collaboration between health care providers, patients and industry is warranted for high-quality, reliable (and actionable) research outputs." Lill-Brith Wium Von Arx, RWE Northen Europe Hub Lead, Eli Lilly & Company
Speaker Interview: Swarna Khare for Novartis
To continue the celebrations for International Women's Day, we also talked with Director of Integrated Evidence Planning, Swarna Khare, representing Novartis. From an overview of what she's excited about this year, to exploring her challenges and wins as a woman in the space, this is one you'll want to read.
In Amsterdam this June, Swarna Khare will join 19 other expert speakers to share their insights on the RWE world, the challenges the lay ahead and potential solutions. Unite to network with peers, learn practical tups and get inspired by what the future looks like.
"For a long time, it is a known fact that CTs have underrepresented female patients. Exclusion of pregnant women, lack of understanding of how hormones can lead to different outcomes, different symptoms between men and women for the same disease have led to underdiagnosis and poorer health outcomes." Swarna Khare, Director of Integrated Evidence Planning, Novartis
